Amprologix joins a global network of innovators
We're proud to announce that Amprologix is one of the 103 finalists selected to participate in the MassChallenge Switzerland & UK Accelerator Programme 2025, chosen from a pool of 1,527 high-potential startups worldwide.
This milestone places Amprologix among a global community of science-driven innovators who are committed to tackling some of the world’s most pressing challenges.
MassChallenge is one of the world’s leading zero-equity startup accelerators. They provide access to industry-leading mentorship, corporate partnerships, and global visibility.
Matt Lashmar, Managing Director, MassChallenge Switzerland:
“Congratulations to all the selected startups! You were chosen by our independent judges from the 1,527 that applied to the Swiss and UK programmes. We look forward to welcoming you in person at bootcamp, so we, our corporate partners, our expert mentor and speakers, and our investment partners can help you grow your businesses, so that you can add value to society.”
At Amprologix, we’re accelerating the discovery and development of next-generation antimicrobials to combat antibiotic resistance: a global health threat affecting millions. Participation in MassChallenge gives us the platform to scale our impact, connect with strategic partners, and drive translational innovation from lab bench to bedside.
Over the coming months, our team will engage in an intensive program of workshops, mentoring, and corporate collaboration, culminating in a final pitch event where top startups will receive funding and global recognition.
